Form D · Biotechnology
GENECURE LLC
Norcross, GA · CIK 0001079273
Offering snapshot reported Feb 21, 2014 · SEC filing
- Reported sold
- Yet to sell Offering amount: $5M
- Investors reported
- 20 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 21, 2014 | Initial | Yet to sell | No comparison | 20 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 04, 05, 4a5
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-212292
Source: Form D, filed Feb 21, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Frank Tung | Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3150 Corners North Court
Norcross, GA, 30071
Norcross, GA, 30071